Enlil Adds Eight MedTech Customers in Record First Quarter of 2026
Enlil announced in a press release that it signed eight new MedTech customers in the first quarter of 2026, marking a record start to the year. The companies span multiple medical technology areas, including organ perfusion, surgical robotics, imaging, and women's health.
The new customers, which include Vascular Perfusion Solutions, Verionyx, and iSono Health, migrated from legacy quality and product lifecycle management systems such as Greenlight Guru and PTC Arena. According to Enlil, its migration team supported these companies in transferring existing development data and establishing new processes without interrupting ongoing work.
Enlil's platform, built for medical device and life sciences organizations, integrates product development, quality, and compliance data with AI capabilities. The company stated that recent customers cited flexibility, integration, and private AI features as key reasons for adopting the platform.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly, Sales & Marketing AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation
The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.
Read more